Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 418

1.

Helical quantum Hall phase in graphene on SrTiO3.

Veyrat L, Déprez C, Coissard A, Li X, Gay F, Watanabe K, Taniguchi T, Han Z, Piot BA, Sellier H, Sacépé B.

Science. 2020 Feb 14;367(6479):781-786. doi: 10.1126/science.aax8201.

PMID:
32054761
2.

Lung Ultrasound in Emergency and Critically Ill Patients: Number of Supervised Exams to Reach Basic Competence.

Arbelot C, Dexheimer Neto FL, Gao Y, Brisson H, Chunyao W, Lv J, Valente Barbas CS, Perbet S, Prior Caltabellotta F, Gay F, Deransy R, Lima EJS, Cebey A, Monsel A, Neves J, Zhang M, Bin D, An Y, Malbouisson L, Salluh J, Constantin JM, Rouby JJ, Biestro A, Vezinet C, Garçon P, El Hadj Kacem N, Lemesle D, Lucena B, de Paula Pinto Schettino G, Cristovao D, de Tarso Roth Dalcin P, Carmona MJC; APECHO Study Group.

Anesthesiology. 2020 Jan 6. doi: 10.1097/ALN.0000000000003096. [Epub ahead of print]

PMID:
31917702
3.

Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple Myeloma.

Bonello F, Mina R, Boccadoro M, Gay F.

Cancers (Basel). 2019 Dec 19;12(1). pii: E15. doi: 10.3390/cancers12010015. Review.

4.

Discovery of a chemical probe for PRDM9.

Allali-Hassani A, Szewczyk MM, Ivanochko D, Organ SL, Bok J, Ho JSY, Gay FPH, Li F, Blazer L, Eram MS, Halabelian L, Dilworth D, Luciani GM, Lima-Fernandes E, Wu Q, Loppnau P, Palmer N, Talib SZA, Brown PJ, Schapira M, Kaldis P, O'Hagan RC, Guccione E, Barsyte-Lovejoy D, Arrowsmith CH, Sanders JM, Kattar SD, Bennett DJ, Nicholson B, Vedadi M.

Nat Commun. 2019 Dec 17;10(1):5759. doi: 10.1038/s41467-019-13652-x.

5.

Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic Strategies.

D'Agostino M, Bertamini L, Oliva S, Boccadoro M, Gay F.

Cancers (Basel). 2019 Dec 13;11(12). pii: E2015. doi: 10.3390/cancers11122015. Review.

6.

Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis.

Bonello F, Pulini S, Ballanti S, Gentile M, Spada S, Annibali O, Omedé P, Ronconi S, Cangialosi C, Podda L, Palmas A, Malfitano A, Rivoli G, Belotti A, Ciambelli F, Vincelli ID, Cafro AM, Innao V, Palumbo A, Sonneveld P, Spencer A, Hájek R, Boccadoro M, Gay F.

Cancers (Basel). 2019 Nov 5;11(11). pii: E1735. doi: 10.3390/cancers11111735.

7.

Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: The FFCD 1104-EVACEL-GTE phase II study.

Walter T, Lepage C, Coriat R, Barbier E, Cadiot G, Caroli-Bosc FX, Aparicio T, Bouhier-Leporrier K, Hentic-Dhome O, Gay F, Dupont-Gossart AC, Duluc M, Lepere C, Lecomte T, Smith D, Petorin C, Di-Fiore F, Ghiringhelli F, Legoux JL, Guimbaud R, Baudin E, Lombard-Bohas C, de Baère T; FFCD 1104 investigators/investigators.

Eur J Cancer. 2019 Dec;123:92-100. doi: 10.1016/j.ejca.2019.09.021. Epub 2019 Oct 31.

PMID:
31678771
8.

Bacterial transportable toxins of the nasopharyngeal microbiota in multiple sclerosis. Nose-to-brain direct.

Gay F.

Rev Neurol (Paris). 2019 Dec;175(10):644-649. doi: 10.1016/j.neurol.2019.09.004. Epub 2019 Oct 16. Review.

PMID:
31629544
9.

Safe Use of Carfilzomib in a Patient with Multiple Myeloma and Intermittent Type 1 Brugada ECG Pattern: A Case Report.

Ghisoni E, Marandino L, Lombardi P, Bonzano A, Becco P, Aglietta M, Fizzotti M, Gay F, Rota Scalabrini D.

Acta Haematol. 2019 Sep 25:1-5. doi: 10.1159/000502538. [Epub ahead of print]

PMID:
31553985
10.

Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation.

Fong JY, Pignata L, Goy PA, Kawabata KC, Lee SC, Koh CM, Musiani D, Massignani E, Kotini AG, Penson A, Wun CM, Shen Y, Schwarz M, Low DH, Rialdi A, Ki M, Wollmann H, Mzoughi S, Gay F, Thompson C, Hart T, Barbash O, Luciani GM, Szewczyk MM, Wouters BJ, Delwel R, Papapetrou EP, Barsyte-Lovejoy D, Arrowsmith CH, Minden MD, Jin J, Melnick A, Bonaldi T, Abdel-Wahab O, Guccione E.

Cancer Cell. 2019 Aug 12;36(2):194-209.e9. doi: 10.1016/j.ccell.2019.07.003.

PMID:
31408619
11.

Insecticide-Treated Mosquito Nets.

Carnevale P, Gay F.

Methods Mol Biol. 2019;2013:221-232. doi: 10.1007/978-1-4939-9550-9_16.

PMID:
31267505
12.

Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs.

Montefusco V, Gay F, Spada S, De Paoli L, Di Raimondo F, Ribolla R, Musolino C, Patriarca F, Musto P, Galieni P, Ballanti S, Nozzoli C, Cascavilla N, Ben-Yehuda D, Nagler A, Hajek R, Offidani M, Liberati AM, Sonneveld P, Cavo M, Corradini P, Boccadoro M.

Haematologica. 2020 Jan;105(1):193-200. doi: 10.3324/haematol.2019.219139. Epub 2019 Jun 20.

13.

On the true identity of Sergentomyia gemmea and description of a closely related species: Se. raynali n. sp.

Depaquit J, Vongphayloth K, Siriyasatien P, Polseela R, Phumee A, Loyer M, Vol A, Varlot G, Rahola N, Brey PT, Sutherland IW, Hertz JC, Gay F, Léger N.

Med Vet Entomol. 2019 Dec;33(4):521-529. doi: 10.1111/mve.12393. Epub 2019 Jun 3.

PMID:
31155766
14.

Redefining the treatment paradigm for multiple myeloma.

Gay F, Mina R.

Lancet Oncol. 2019 Jun;20(6):743-744. doi: 10.1016/S1470-2045(19)30295-5. Epub 2019 May 13. No abstract available.

PMID:
31097404
15.

Cardiovascular Organ Damage and Blood Pressure Levels Predict Adverse Events in Multiple Myeloma Patients Undergoing Carfilzomib Therapy.

Bruno G, Bringhen S, Maffei I, Iannaccone A, Crea T, Ravera A, Astarita A, Vallelonga F, Salvini M, Gay F, Veglio F, Milan A.

Cancers (Basel). 2019 May 3;11(5). pii: E622. doi: 10.3390/cancers11050622.

16.

Epidemiologic Trends in Malaria Incidence Among Travelers Returning to Metropolitan France, 1996-2016.

Kendjo E, Houzé S, Mouri O, Taieb A, Gay F, Jauréguiberry S, Tantaoui I, Ndour PA, Buffet P, Piarroux M, Thellier M, Piarroux R; French Imported Malaria Study Group.

JAMA Netw Open. 2019 Apr 5;2(4):e191691. doi: 10.1001/jamanetworkopen.2019.1691.

17.

Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study.

Plesner T, Arkenau HT, Gay F, Minnema MC, Boccadoro M, Moreau P, Cavenagh J, Perrot A, Laubach JP, Krejcik J, Ahmadi T, de Boer C, Chen D, Chiu C, Schecter JM, Richardson PG.

Br J Haematol. 2019 Aug;186(3):e35-e39. doi: 10.1111/bjh.15879. Epub 2019 Mar 31. No abstract available.

PMID:
30931524
18.

CyTOF®: A New Tool to Decipher the Immunomodulatory Activity of Daratumumab.

Castella B, Mina R, Gay F.

Cytometry A. 2019 Apr;95(4):416-418. doi: 10.1002/cyto.a.23752. Epub 2019 Mar 25. No abstract available.

PMID:
30908843
19.

Sensitivity of the superconducting state in thin films.

Tamir I, Benyamini A, Telford EJ, Gorniaczyk F, Doron A, Levinson T, Wang D, Gay F, Sacépé B, Hone J, Watanabe K, Taniguchi T, Dean CR, Pasupathy AN, Shahar D.

Sci Adv. 2019 Mar 15;5(3):eaau3826. doi: 10.1126/sciadv.aau3826. eCollection 2019 Mar.

20.

Leishmaniasis.

Depaquit J, Gay F, Kaltenbach ML.

Lancet. 2019 Mar 2;393(10174):871-872. doi: 10.1016/S0140-6736(18)33077-0. No abstract available.

PMID:
30837139
21.

Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension.

Bringhen S, Milan A, D'Agostino M, Ferri C, Wäsch R, Gay F, Larocca A, Offidani M, Zweegman S, Terpos E, Goldschmidt H, Cavo M, Ludwig H, Driessen C, Auner HW, Caers J, Gramatzki M, Dimopoulos MA, Boccadoro M, Einsele H, Sonneveld P, Engelhardt M.

J Intern Med. 2019 Jul;286(1):63-74. doi: 10.1111/joim.12882. Epub 2019 Apr 8.

PMID:
30725503
22.

Do we need cytogenetics in the follow-up of multiple myeloma?

Gay F, Goldschmidt H.

Br J Haematol. 2019 May;185(3):399-401. doi: 10.1111/bjh.15781. Epub 2019 Feb 1. No abstract available.

PMID:
30706441
23.

Low-Magnetic-Field Regime of a Gate-Defined Constriction in High-Mobility Graphene.

Veyrat L, Jordan A, Zimmermann K, Gay F, Watanabe K, Taniguchi T, Sellier H, Sacépé B.

Nano Lett. 2019 Feb 13;19(2):635-642. doi: 10.1021/acs.nanolett.8b02584. Epub 2019 Jan 24.

PMID:
30654611
24.

Low-temperature anomaly in disordered superconductors near B c2 as a vortex-glass property.

Sacépé B, Seidemann J, Gay F, Davenport K, Rogachev A, Ovadia M, Michaeli K, Feigel'man MV.

Nat Phys. 2019 Jan;15(1):48-53. doi: 10.1038/s41567-018-0294-6. Epub 2018 Oct 8.

25.

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.

Dimopoulos MA, Gay F, Schjesvold F, Beksac M, Hajek R, Weisel KC, Goldschmidt H, Maisnar V, Moreau P, Min CK, Pluta A, Chng WJ, Kaiser M, Zweegman S, Mateos MV, Spencer A, Iida S, Morgan G, Suryanarayan K, Teng Z, Skacel T, Palumbo A, Dash AB, Gupta N, Labotka R, Rajkumar SV; TOURMALINE-MM3 study group.

Lancet. 2019 Jan 19;393(10168):253-264. doi: 10.1016/S0140-6736(18)33003-4. Epub 2018 Dec 10.

PMID:
30545780
26.

Promises and Pitfalls in the Use of PD-1/PD-L1 Inhibitors in Multiple Myeloma.

Oliva S, Troia R, D'Agostino M, Boccadoro M, Gay F.

Front Immunol. 2018 Nov 27;9:2749. doi: 10.3389/fimmu.2018.02749. eCollection 2018. Review.

27.

Special problems in the management of elderly patients with multiple myeloma.

Gay F, Larocca A.

Eur J Intern Med. 2018 Dec;58:64-69. doi: 10.1016/j.ejim.2018.05.027. Review.

PMID:
30527921
28.

Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials.

D'Agostino M, De Paoli L, Conticello C, Offidani M, Ria R, Petrucci MT, Spada S, Marcatti M, Catalano L, Gilestro M, Guglielmelli T, Baldini L, Gamberi B, Rizzi R, De Sabbata G, Di Renzo N, Patriarca F, Pezzatti S, Siniscalchi A, Ribolla R, Palumbo A, Montefusco V, Nagler A, Boccadoro M, Gay F.

Crit Rev Oncol Hematol. 2018 Dec;132:9-16. doi: 10.1016/j.critrevonc.2018.09.008. Epub 2018 Sep 14. Review.

PMID:
30447931
29.

Changes in the gills of the European eel (Anguilla anguilla) after chronic exposure to environmental cocaine concentration.

Capaldo A, Gay F, Laforgia V.

Ecotoxicol Environ Saf. 2019 Mar;169:112-119. doi: 10.1016/j.ecoenv.2018.11.010. Epub 2018 Nov 13.

PMID:
30445241
30.

CD38 as an immunotherapeutic target in multiple myeloma.

Bonello F, D'Agostino M, Moscvin M, Cerrato C, Boccadoro M, Gay F.

Expert Opin Biol Ther. 2018 Dec;18(12):1209-1221. doi: 10.1080/14712598.2018.1544240. Epub 2018 Nov 13. Review.

PMID:
30394809
31.

Shade trees have higher impact on soil nutrient availability and food web in organic than conventional coffee agroforestry.

Sauvadet M, den Meersche KV, Allinne C, Gay F, de Melo Virginio Filho E, Chauvat M, Becquer T, Tixier P, Harmand JM.

Sci Total Environ. 2019 Feb 1;649:1065-1074. doi: 10.1016/j.scitotenv.2018.08.291. Epub 2018 Aug 25.

PMID:
30308878
32.

The Mechanical Ventilation-Respiratory Distress Observation Scale as a surrogate of self-reported dyspnoea in intubated patients.

Decavèle M, Gay F, Persichini R, Mayaux J, Morélot-Panzini C, Similowski T, Demoule A.

Eur Respir J. 2018 Oct 10;52(4). pii: 1800598. doi: 10.1183/13993003.00598-2018. Print 2018 Oct. No abstract available.

PMID:
30209199
33.

European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when.

Caers J, Garderet L, Kortüm KM, O'Dwyer ME, van de Donk NWCJ, Binder M, Dold SM, Gay F, Corre J, Beguin Y, Ludwig H, Larocca A, Driessen C, Dimopoulos MA, Boccadoro M, Gramatzki M, Zweegman S, Einsele H, Cavo M, Goldschmidt H, Sonneveld P, Delforge M, Auner HW, Terpos E, Engelhardt M.

Haematologica. 2018 Nov;103(11):1772-1784. doi: 10.3324/haematol.2018.189159. Epub 2018 Aug 31. Review.

34.

Aspergillus PCR in Bronchoalveolar Lavage Fluid for the Diagnosis and Prognosis of Aspergillosis in Patients With Hematological and Non-hematological Conditions.

Imbert S, Meyer I, Palous M, Brossas JY, Uzunov M, Touafek F, Gay F, Trosini-Desert V, Fekkar A.

Front Microbiol. 2018 Aug 14;9:1877. doi: 10.3389/fmicb.2018.01877. eCollection 2018.

35.

Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysis.

Gay F, Jackson G, Rosiñol L, Holstein SA, Moreau P, Spada S, Davies F, Lahuerta JJ, Leleu X, Bringhen S, Evangelista A, Hulin C, Panzani U, Cairns DA, Di Raimondo F, Macro M, Liberati AM, Pawlyn C, Offidani M, Spencer A, Hájek R, Terpos E, Morgan GJ, Bladé J, Sonneveld P, San-Miguel J, McCarthy PL, Ludwig H, Boccadoro M, Mateos MV, Attal M.

JAMA Oncol. 2018 Oct 1;4(10):1389-1397. doi: 10.1001/jamaoncol.2018.2961.

36.

Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA).

Bringhen S, Milan A, Ferri C, Wäsch R, Gay F, Larocca A, Salvini M, Terpos E, Goldschmidt H, Cavo M, Petrucci MT, Ludwig H, Auner HW, Caers J, Gramatzki M, Boccadoro M, Einsele H, Sonneveld P, Engelhardt M; European Hematology Association, the European Myeloma Network and the Italian Society of Arterial Hypertension.

Haematologica. 2018 Sep;103(9):1422-1432. doi: 10.3324/haematol.2018.191288. Epub 2018 Jul 26. Review.

37.

European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias.

Gavriatopoulou M, Musto P, Caers J, Merlini G, Kastritis E, van de Donk N, Gay F, Hegenbart U, Hajek R, Zweegman S, Bruno B, Straka C, Dimopoulos MA, Einsele H, Boccadoro M, Sonneveld P, Engelhardt M, Terpos E.

Leukemia. 2018 Sep;32(9):1883-1898. doi: 10.1038/s41375-018-0209-7. Epub 2018 Jul 23. Review.

38.

Visceral Leishmaniasis in Traveler to Guyana Caused by Leishmania siamensis, London, UK.

Depaquit J, Kaltenbach ML, Gay F.

Emerg Infect Dis. 2018 Aug;24(8):1599-1600. doi: 10.3201/eid2408.172147. No abstract available.

39.

Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN).

Larocca A, Dold SM, Zweegman S, Terpos E, Wäsch R, D'Agostino M, Scheubeck S, Goldschmidt H, Gay F, Cavo M, Ludwig H, Straka C, Bringhen S, Auner HW, Caers J, Gramatzki M, Offidani M, Dimopoulos MA, Einsele H, Boccadoro M, Sonneveld P, Engelhardt M.

Leukemia. 2018 Aug;32(8):1697-1712. doi: 10.1038/s41375-018-0142-9. Epub 2018 Apr 25. Review.

40.

Effects of environmental cocaine concentrations on the skeletal muscle of the European eel (Anguilla anguilla).

Capaldo A, Gay F, Lepretti M, Paolella G, Martucciello S, Lionetti L, Caputo I, Laforgia V.

Sci Total Environ. 2018 Nov 1;640-641:862-873. doi: 10.1016/j.scitotenv.2018.05.357. Epub 2018 Jun 5.

PMID:
29879672
41.

Clinical and Pharmacologic Features of Monoclonal Antibodies and Checkpoint Blockade Therapy in Multiple Myeloma.

D'Agostino M, Gazzera G, Cetani G, Bringhen S, Boccadoro M, Gay F.

Curr Med Chem. 2019;26(32):5968-5981. doi: 10.2174/0929867325666180514114806. Review.

PMID:
29756564
42.

Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network.

Ludwig H, Delforge M, Facon T, Einsele H, Gay F, Moreau P, Avet-Loiseau H, Boccadoro M, Hajek R, Mohty M, Cavo M, Dimopoulos MA, San-Miguel JF, Terpos E, Zweegman S, Garderet L, Mateos MV, Cook G, Leleu X, Goldschmidt H, Jackson G, Kaiser M, Weisel K, van de Donk NWCJ, Waage A, Beksac M, Mellqvist UH, Engelhardt M, Caers J, Driessen C, Bladé J, Sonneveld P.

Leukemia. 2018 Jul;32(7):1542-1560. doi: 10.1038/s41375-018-0040-1. Epub 2018 May 2. Review.

43.

Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis.

Cerrato C, Di Raimondo F, De Paoli L, Spada S, Patriarca F, Crippa C, Mina R, Guglielmelli T, Ben-Yehuda D, Oddolo D, Nozzoli C, Angelucci E, Cascavilla N, Rizzi R, Rocco S, Baldini L, Ponticelli E, Marcatti M, Cangialosi C, Caravita T, Benevolo G, Ria R, Nagler A, Musto P, Tacchetti P, Corradini P, Offidani M, Palumbo A, Petrucci MT, Boccadoro M, Gay F.

J Cancer Res Clin Oncol. 2018 Jul;144(7):1357-1366. doi: 10.1007/s00432-018-2641-5. Epub 2018 Apr 19.

PMID:
29675792
44.

Evaluation of Cardiovascular Toxicity Associated with Treatments Containing Proteasome Inhibitors in Multiple Myeloma Therapy.

Iannaccone A, Bruno G, Ravera A, Gay F, Salvini M, Bringhen S, Sabia L, Avenatti E, Veglio F, Milan A.

High Blood Press Cardiovasc Prev. 2018 Jun;25(2):209-218. doi: 10.1007/s40292-018-0256-1. Epub 2018 Mar 26.

PMID:
29582365
45.

Radiofrequency Ablation of Liver Tumors: No Difference in the Ablation Zone Volume Between Cirrhotic and Healthy Liver.

Cassinotto C, Denys A, Gay F, Duran R, Hocquelet A, Piron L, Guiu B.

Cardiovasc Intervent Radiol. 2018 Jun;41(6):905-911. doi: 10.1007/s00270-018-1898-z. Epub 2018 Feb 26.

PMID:
29484466
46.

Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?

Leleu X, Gay F, Flament A, Allcott K, Delforge M.

Ann Hematol. 2018 Mar;97(3):387-400. doi: 10.1007/s00277-017-3191-7. Epub 2017 Dec 27. Review.

47.

Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe).

Nanni C, Versari A, Chauvie S, Bertone E, Bianchi A, Rensi M, Bellò M, Gallamini A, Patriarca F, Gay F, Gamberi B, Ghedini P, Cavo M, Fanti S, Zamagni E.

Eur J Nucl Med Mol Imaging. 2018 May;45(5):712-719. doi: 10.1007/s00259-017-3909-8. Epub 2017 Dec 21.

PMID:
29270787
48.

Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network.

Ludwig H, Delforge M, Facon T, Einsele H, Gay F, Moreau P, Avet-Loiseau H, Boccadoro M, Hajek R, Mohty M, Cavo M, Dimopoulos MA, San-Miguel JF, Terpos E, Zweegman S, Garderet L, Mateos MV, Cook G, Leleu X, Goldschmidt H, Jackson G, Kaiser M, Weisel K, van de Donk NWCJ, Waage A, Beksac M, Mellqvist UH, Engelhardt M, Caers J, Driessen C, Sonneveld P.

Leukemia. 2017 Dec 18. doi: 10.1038/leu.2017.353. [Epub ahead of print] Review.

PMID:
29251284
49.

From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives.

Gay F, Engelhardt M, Terpos E, Wäsch R, Giaccone L, Auner HW, Caers J, Gramatzki M, van de Donk N, Oliva S, Zamagni E, Garderet L, Straka C, Hajek R, Ludwig H, Einsele H, Dimopoulos M, Boccadoro M, Kröger N, Cavo M, Goldschmidt H, Bruno B, Sonneveld P.

Haematologica. 2018 Feb;103(2):197-211. doi: 10.3324/haematol.2017.174573. Epub 2017 Dec 7. Review.

50.

Autologous transplant for myeloma: when the old meets the new.

Gay F, Genuardi M, Boccadoro M.

Oncotarget. 2017 Oct 8;8(53):90618-90619. doi: 10.18632/oncotarget.21605. eCollection 2017 Oct 31. No abstract available.

Supplemental Content

Support Center